• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用冷血心脏停搏液预防缺血再灌注所致的冠状动脉微循环损伤。

Use of cold blood cardioplegia to protect against coronary microcirculatory injury due to ischemia and reperfusion.

作者信息

McDonagh P F, Laks H

出版信息

J Thorac Cardiovasc Surg. 1982 Oct;84(4):609-18.

PMID:7121048
Abstract

The effect of cold blood cardioplegia in preventing microvascular injury owing to myocardial ischemia and reperfusion was studied. Two groups of eight dogs each were placed on cardiopulmonary bypass with separate coronary perfusion at 80 mm Hg. Microcirculatory function was assessed by measuring the extraction and permeability surface area product (PS) for inulin and albumin. These changes were correlated with the transport and extraction of oxygen, coronary blood flow, and morphologic studies of the microvasculature. In Group I, ischemic hearts were kept normothermic for 45 minutes. In Group II, 250 ml of cold (4 degrees C) blood cardioplegic solution (potassium chloride 30 mEq/L) was infused and the infusion repeated at 15 and 30 minutes. Reperfusion resulted in marked reactive hyperemia for Group I (p less than 0.05) but no hyperemic response in Group II. In Group I, but not II, ischemia-reperfusion caused a significant decrease in PS inulin (0.47 +/- 0.10 ml/min/gm) compared to the preischemic value (1.04 +/- 0.23) (p less than 0.05). There was a threefold decrease in the PS inulin/PS albumin ratio with reperfusion in Group I, indicating increased vascular permeability to albumin. There was also a significant decrease in myocardial oxygen consumption (from 5.1 +/- 0.7 to 3.4 +/- 0.5 ml/min/100 gm, p less than 0.05) for Group I. These did not decrease for Group II. Histologic studies showed diffused areas of no reflow in the unprotected hearts. The wet/dry weight ratio for Group I (4.97 +/- 0.09) was significantly greater than for Group II (4.49 +/- 0.07) (p less than 0.001). The results indicate that in the unprotected heart, ischemia-reperfusion caused microcirculatory injury resulting in increased permeability to albumin, edema, a reduction in surface area, and areas of no reflow. In contrast, in the hearts protected with cold blood cardioplegia, no evidence of microcirculatory injury occurred.

摘要

研究了冷血心脏停搏液在预防心肌缺血再灌注所致微血管损伤中的作用。将两组各8只犬置于体外循环,冠状动脉以80 mmHg的压力单独灌注。通过测量菊粉和白蛋白的摄取及通透面积乘积(PS)来评估微循环功能。这些变化与氧的转运和摄取、冠状动脉血流量以及微血管的形态学研究相关。在第一组中,缺血心脏保持常温45分钟。在第二组中,输注250 ml冷(4℃)血心脏停搏液(氯化钾30 mEq/L),并在15分钟和30分钟时重复输注。再灌注导致第一组出现明显的反应性充血(p<0.05),而第二组无充血反应。与缺血前值(1.04±0.23)相比,第一组但非第二组的缺血再灌注导致菊粉PS显著降低(0.47±0.10 ml/min/gm)(p<0.05)。第一组再灌注时菊粉PS/白蛋白PS比值降低了三倍,表明血管对白蛋白的通透性增加。第一组心肌耗氧量也显著降低(从5.1±0.7降至3.4±0.5 ml/min/100 gm,p<0.05)。第二组则未降低。组织学研究显示未保护心脏中有弥漫性无复流区域。第一组的湿/干重比值(4.97±0.09)显著高于第二组(4.49±0.07)(p<0.001)。结果表明,在未保护的心脏中,缺血再灌注导致微血管损伤,从而使白蛋白通透性增加、水肿、表面积减少以及出现无复流区域。相比之下,在用冷血心脏停搏液保护的心脏中,未出现微血管损伤的证据。

相似文献

1
Use of cold blood cardioplegia to protect against coronary microcirculatory injury due to ischemia and reperfusion.使用冷血心脏停搏液预防缺血再灌注所致的冠状动脉微循环损伤。
J Thorac Cardiovasc Surg. 1982 Oct;84(4):609-18.
2
Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia.长时间主动脉阻断期间的心肌保护。血液停搏液与晶体停搏液的比较。
J Thorac Cardiovasc Surg. 1984 Sep;88(3):411-23.
3
Failure of blood cardioplegia to protect myocardium at lower temperatures.
Circulation. 1982 Aug;66(2 Pt 2):I60-7.
4
Myocardial energetics after thermally graded hyperkalemic crystalloid cardioplegic arrest.
J Thorac Cardiovasc Surg. 1986 Jul;92(1):56-62.
5
Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.缺血后控制性再灌注的研究。第十九部分。再灌注液成分:在局部再灌注期间血液停搏液优于氟碳化合物DA停搏液的益处——初始再灌注液中包含血液成分的重要性。
J Thorac Cardiovasc Surg. 1991 Feb;101(2):284-93.
6
Continuous versus intermittent warm blood cardioplegia: functional and energetics changes.持续与间歇性温血心脏停搏液灌注:功能及能量学变化
Ann Thorac Surg. 1996 Oct;62(4):1172-8; discussion 1178-9. doi: 10.1016/0003-4975(96)00598-X.
7
Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.缺血性停搏期间增强心肌保护。晶体心脏停搏液的氧合。
J Thorac Cardiovasc Surg. 1983 May;85(5):769-80.
8
Effects of reperfusion after acute coronary occlusion on the beating, working heart compared to the arrested heart treated locally and globally with cardioplegia.急性冠状动脉闭塞后再灌注对跳动的工作心脏的影响,与局部和整体使用心脏停搏液处理的停跳心脏相比。
J Thorac Cardiovasc Surg. 1984 Apr;87(4):561-6.
9
Effect of calcium and preischemic hypothermia on recovery of myocardial function after cardioplegic ischemia in neonatal lambs.钙和缺血前低温对新生羔羊心脏停搏缺血后心肌功能恢复的影响。
J Thorac Cardiovasc Surg. 1993 Feb;105(2):207-12; discussion 212-3.
10
Cold-blood potassium cardioplegia: evaluation of glutathione and postischemic cardioplegia.
J Thorac Cardiovasc Surg. 1979 Dec;78(6):893-907.

引用本文的文献

1
Perfusion preservation of the donor heart: basic science to pre-clinical.供体心脏的灌注保存:从基础科学到临床前研究
J Extra Corpor Technol. 2009 Sep;41(3):140-8.
2
The role of the coronary microcirculation in myocardial recovery from ischemia.冠状动脉微循环在心肌缺血后恢复中的作用。
Yale J Biol Med. 1983 Jul-Aug;56(4):303-11.